Chapter 3 Familial Hemiplegic Migraine

Advances in Genetics

Volumn 63, Issue , 2008, Pages 57-83

  Barrett, Curtis F ^a   van den Maagdenberg, Arn M J M ^a   Frants, Rune R ^a   Ferrari, Michel D ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; DISEASE MODEL; EPILEPSY; GENETICS; HUMAN; MIGRAINE WITH AURA; MUTATION; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SPREADING CORTICAL DEPRESSION;

ANIMALS; DISEASE MODELS, ANIMAL; EPILEPSY; HUMANS; MIGRAINE WITH AURA; MUTATION; SPREADING CORTICAL DEPRESSION;

EID: 58649116477     PISSN: 00652660     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-2660(08)01003-1     Document Type: Review

References (129)

1. Adams P.J., and Snutch T.P. Calcium channelopathies: Voltage-gated calcium channels. Subcell Biochem 45 (2007) 215-251
2. Akerman S., and Goadsby P.J. Topiramate inhibits cortical spreading depression in rat and cat: Impact in migraine aura. NeuroReport 16 (2005) 1383-1387
3. Ambrosini A., D'Onofrio M., Grieco G.S., Di Mambro A., Fortini D., Nicoletti F., Nappi G., Sances G., Schoenen J., Buzzi M.G., Santorelli F.M., and Pierelli F. A new mutation on the ATPA2 gene in one Italian family with basilar-type migraine linked to the FHM2 locus. Neurology 64 (2005) A132
4. Andlin-Sobocki P., Jonsson B., Wittchen H.U., and Olesen J. Cost of disorders of the brain in Europe. Eur. J. Neurol. 12 (2005) 1-27
5. Ayata C., Shimizu-Sasamata M., Lo E.H., Noebels J.L., and Moskowitz M.A. Impaired neurotransmitter release and elevated threshold for cortical spreading depression in mice with mutations in the alpha 1A subunit of P/Q type calcium channels. Neuroscience 95 (2000) 639-645
6. Ayata C., Jin H., Kudo C., Dalkara T., and Moskowitz M.A. Suppression of cortical spreading depression in migraine prophylaxis. Ann. Neurol. 59 (2006) 652-661
7. Bahra A., May A., and Goadsby P.J. Cluster headache: A prospective clinical study in 230 patients with diagnostic implications. Neurology 58 (2002) 354-361
8. Banner S.J., Fray A.E., Ince P.G., Steward M., Cookson M.R., and Shaw P.J. The expression of the glutamate re-uptake transporter excitatory amino acid transporter 1 (EAAT1) in the normal human CNS and in motor neurone disease: An immunohistochemical study. Neuroscience 109 (2002) 27-44
9. Barrett C.F., Cao Y.Q., and Tsien R.W. Gating deficiency in a familial hemiplegic migraine type 1 mutant P/Q-type calcium channel. J. Biol. Chem. 280 (2005) 24064-24071
10. Bassi M.T., Bresolin N., Tonelli A., Nazos K., Crippa F., Baschirotto C., Zucca C., Bersano A., Dolcetta D., Boneschi F.M., Barone V., and Casari G. A novel mutation in the ATP1A2 gene causes alternating hemiplegia of childhood. J. Med. Genet. 41 (2004) 621-628
11. Blau J.N. Migraine: Theories of pathogenesis. Lancet 339 (1992) 1202-1207
12. Bolay H., Reuter U., Dunn A.K., Huang Z., Boas D.A., and Moskowitz M.A. Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat. Med. 8 (2002) 136-142
13. Bousser M.G., and Welch K.M. Relation between migraine and stroke. Lancet Neurol. 4 (2005) 533-542
14. Breslau N., and Davis G.C. Migraine, physical health and psychiatric disorder: A prospective epidemiological study in young adults. J. Psychiatr. Res. 27 (1993) 211-221
15. Breslau N., Lipton R.B., Stewart W.F., Schultz L.R., and Welch K.M. Comorbidity of migraine and depression: Investigating potential etiology and prognosis. Neurology 60 (2003) 1308-1312
16. Cao Y.Q., and Tsien R.W. Effects of familial hemiplegic migraine type 1 mutations on neuronal P/Q-type Ca2+ channel activity and inhibitory synaptic transmission. Proc. Natl Acad. Sci. USA 102 (2005) 2590-2595
17. 2+ channelopathy. Neuron 43 (2004) 387-400
18. Capendeguy O.O., and Horisberger J.D. Functional effects of Na+, K+ ATPase gene mutations linked to familial hemiplegic migraine. Neuromol. Med. 6 (2004) 105-116
19. Catterall W.A. Structure and function of neuronal Ca2+ channels and their role in neurotransmitter release. Cell Calcium 24 (1998) 307-323
20. Claes L., Del-Favero J., Ceulemans B., Lagae L., Van Broeckhoven C., and De Jonghe P. De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. Am. J. Hum. Genet. 68 (2001) 1327-1332
21. + pump α2 subunit associated with familial hemiplegic migraine type 2. Nat. Genet. 33 (2003) 192-196
22. de Vries B., Freilinger T., Vanmolkot K.R., Koenderink J.B., Stam A.H., Terwindt G.M., Babini E., van den Boogerd E.H., van den Heuvel J.J., Frants R.R., Haan J., Pusch M., van den Maagdenberg A.M., Ferrari M.D., and Dichgans M. Systematic analysis of three FHM genes in 39 sporadic patients with hemiplegic migraine. Neurology 69 (2007) 2170-2176
23. Dichgans M., Freilinger T., Eckstein G., Babini E., Lorenz-Depiereux B., Biskup S., Ferrari M.D., Herzog J., van den Maagdenberg A.M., Pusch M., and Strom T.M. Mutation in the neuronal voltage-gated sodium channel SCN1A causes familial hemiplegic migraine. Lancet 366 (2005) 371-377
24. Dove L.S., Abbott L.C., and Griffit W.H. Whole-cell and single-channel analysis of P-type calcium currents in cerebellar purkinje cells of leaner mutant mice. J. Neurosci. 18 (1998) 7687-7699
25. Ducros A., Denier C., Joutel A., Cecillon M., Lescoat C., Vahedi K., Darcel F., Vicaut E., Bousser M.G., and Tournier-Lasserve E. The clinical spectrum of familial hemiplegic migraine associated with mutations in a neuronal calcium channel. N. Engl. J. Med. 345 (2001) 17-24
26. Eikermann-Haerter K., and Moskowitz M.A. Animal models of migraine headache and aura. Curr. Opin. Neurol. 21 (2008) 294-300
27. Fernandez D.M., Hand C.K., Sweeney B.J., and Parfrey N.A. A novel ATP1A2 gene mutation in an Irish familial hemiplegic migraine kindred. Headache 48 (2008) 101-108
28. Ferrari M.D. Migraine. Lancet 351 (1998) 1043-1051
29. Fujiwara T., Sugawara T., Mazaki-Miyazaki E., Takahashi Y., Fukushima K., Watanabe M., Hara K., Morikawa T., Yagi K., Yamakawa K., and Inoue Y. Mutations of sodium channel alpha subunit type 1 (SCN1A) in intractable childhood epilepsies with frequent generalized tonic-clonic seizures. Brain 126 (2003) 531-546
30. Gargus J.J., and Tournay A. Novel mutation confirms seizure locus SCN1A is also familial hemiplegic migraine locus FHM3. Pediatr. Neurol. 37 (2007) 407-410
31. Gervil M., Ulrich V., Kaprio J., Olesen J., and Russell M.B. The relative role of genetic and environmental factors in migraine without aura. Neurology 53 (1999) 995-999
32. Giffin N.J., Ruggiero L., Lipton R.B., Silberstein S., Tvedskov J.F., Olesen J., Altman J., Goadsby P.J., and Macrae A. Premonitory symptoms in migraine: An electronic diary study. Neurology 60 (2003) 935-940
33. Giffin N.J., Lipton R.B., Silberstein S.D., Tvedskov J.F., Olesen J., and Goadsby P.J. The migraine postdrome: An electronic diary study. Cephalalgia 25 (2005) 958
34. Goadsby P.J. Migraine, aura and cortical spreading depression: Why are we still talking about it?. Ann. Neurol. 49 (2001) 4-6
35. Goadsby P.J., Lipton R.B., and Ferrari M.D. Migraine-Current understanding and treatment. N. Engl. J. Med. 346 (2002) 257-270
36. Guida S., Trettel F., Pagnutti S., Mantuano E., Tottene A., Veneziano L., Fellin T., Spadaro M., Stauderman K., Williams M., Volsen S., Ophoff R., Frants R., Jodice C., Frontali M., and Pietrobon D. Complete loss of P/Q calcium channel activity caused by a CACNA1A missense mutation carried by patients with episodic ataxia type 2. Am. J. Hum. Genet. 68 (2001) 759-764
37. Haan J., Kors E.E., Vanmolkot K.R., van den Maagdenberg A.M., Frants R.R., and Ferrari M.D. Migraine genetics: An update. Curr. Pain Headache Rep. 9 (2005) 213-220
38. Hadjikhani N., Sanchez del Rio M., Wu O., Schwartz D., Bakker D., Fischl B., Wong K.K., Cutrer F.M., Rosen B.R., Tootell R.B.H., Sorensen A.G., and Moskowitz M.A. Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc. Natl Acad. Sci. USA 98 (2001) 4687-4692
39. Haerter K., Ayata C., and Moskowitz M.A. Cortical spreading depression: A model for understanding migraine biology and future drug targets. Headache Currents 2 (2005) 97-103
40. Hans M., Luvisetto S., Williams M.E., Spagnolo M., Urrutia A., Tottene A., Brust P.F., Johnson E.C., Harpold M.M., Stauderman K.A., and Pietrobon D. Functional consequences of mutations in the human alpha(1A) calcium channel subunit linked to familial hemiplegic migraine. J. Neurosci. 19 (1999) 1610-1619
41. Haut S.R., Bigal M.E., and Lipton R.B. Chronic disorders with episodic manifestations: Focus on epilepsy and migraine. Lancet Neurol. 5 (2006) 148-157
42. Headache Classification Committee of The International Headache Society. The International Classification of Headache Disorders (second edition). Cephalalgia 24 (2004) 1-160
43. Hirschhorn J.N., and Daly M.J. Genome-wide association studies for common diseases and complex traits. Nat. Rev. Genet. 6 (2005) 95-108
44. Honkasalo M.L., Kaprio J., Winter T., Heikkilä K., Sillanpää M., and Koskenvuo M. Migraine and concomitant symptoms among 8167 adult twin pairs. Headache 35 (1995) 70-78
45. Ikeda K., Onaka T., Yamakado M., Nakai J., Ishikawa T.O., Taketo M.M., and Kawakami K. Degeneration of the amygdala/piriform cortex and enhanced fear/anxiety behaviors in sodium pump alpha2 subunit (Atp1a2)-deficient mice. J. Neurosci. 23 (2003) 4667-4676
46. - homeostasis in brainstem neurons. J. Neurosci. 24 (2004) 10693-10701
47. V 2.1 in absence epilepsy and episodic ataxia. Brain 127 (2004) 2682-2692
48. James P.F., Grupp I.L., Grupp G., Woo A.L., Askew G.R., Croyle M.L., Walsh R.A., and Lingrel J.B. Identification of a specific role for the Na,K-ATPase alpha 2 isoform as a regulator of calcium in the heart. Mol. Cell 3 (1999) 555-563
49. Jen J., Wan J., Graves M., Yu H., Mock A.F., Coulin C.J., Kim G., Yue Q., Papazian D.M., and Baloh R.W. Loss-of-function EA2 mutations are associated with impaired neuromuscular transmission. Neurology 57 (2001) 1843-1848
50. Jen J., Kim G.W., and Baloh R.W. Clinical spectrum of episodic ataxia type 2. Neurology 62 (2004) 17-22
51. Jen J.C., Wan J., Palos T.P., Howard B.D., and Baloh R.W. Mutation in the glutamate transporter EAAT1 causes episodic ataxia, hemiplegia, and seizures. Neurology 65 (2005) 529-534
52. 2+ channel mutations associated with episodic ataxia type 2. Am. J. Physiol. Cell Physiol. 290 (2006) 1209-1220
53. Jouvenceau A., Eunson L.H., Spauschus A., Ramesh V., Zuberi S.M., Kullmann D.M., and Hanna M.G. Human epilepsy associated with dysfunction of the brain P/Q-type calcium channel. Lancet 358 (2001) 801-807
54. Kaja S., van de Ven R.C., Broos L.A., Veldman H., van Dijk J.G., Verschuuren J.J., Frants R.R., Ferrari M.D., van den Maagdenberg A.M., and Plomp J.J. Gene dosage-dependent transmitter release changes at neuromuscular synapses of CACNA1A R192Q knockin mice are non-progressive and do not lead to morphological changes or muscle weakness. Neuroscience 135 (2005) 81-95
55. Kallela M., Wessman M., Havanka H., Palotie A., and Farkkila M. Familial migraine with and without aura: Clinical characteristics and co-occurrence. Eur. J. Neurol. 8 (2001) 441-449
56. Kaube H., Herzog J., Kaufer T., Dichgans M., and Diener H.C. Aura in some patients with familial hemiplegic migraine can be stopped by intranasal ketamine. Neurology 55 (2000) 139-141
57. Kawakami H., Tanaka K., Nakayama T., Inoue K., and Nakamura S. Cloning and expression of a human glutamate transporter. Biochem. Biophys. Res. Commun. 199 (1994) 171-176
58. Kelman L. The postdrome of the acute migraine attack. Cephalalgia 26 (2006) 214-220
59. Koenderink J.B., Zifarelli G., Qiu L.Y., Schwarz W., De Pont J.J.H.H.M., Bamberg E., and Friedrich T. Na,K-ATPase mutations in familial hemiplegic migraine lead to functional inactivation. Biochim. Biophys. Acta 1669 (2005) 61-68
60. Kors E.E., Terwindt G.M., Vermeulen F.L.M.G., Fitzsimons R.B., Jardine P.E., Heywood P., Love S., van den Maagdenberg A.M.J.M., Haan J., Frants R.R., and Ferrari M.D. Delayed cerebral edema and fatal coma after minor head trauma: Role of CACNA1A calcium channel subunit gene and relationship with familial hemiplegic migraine. Ann. Neurol. 49 (2001) 753-760
61. Kors E.E., Vanmolkot K.R., Haan J., Frants R.R., van den Maagdenberg A.M., and Ferrari M.D. Recent findings in headache genetics. Curr. Opin. Neurol. 17 (2004) 283-288
62. 2+ channel kinetics. J. Biol. Chem. 273 (1998) 5586-5590
63. Kraus R.L., Sinnegger M.J., Koschak A., Glossmann H., Stenirri S., Carrera P., and Striessnig J. Three new familial hemiplegic migraine mutants affect P/Q-type Ca(2+) channel kinetics. J. Biol. Chem. 275 (2000) 9239-9243
64. Kruit M.C., van Buchem M.A., Hofman P.A., Bakkers J.T., Terwindt G.M., Ferrari M.D., and Launer L.J. Migraine as a risk factor for subclinical brain lesions. J. Am. Med. Assoc. 291 (2004) 427-434
65. Lashley K.S. Patterns of cerebral integration indicated by the scotomas of migraine. Arch. Neurol. Psychiatry 46 (1941) 331-339
66. Lauritzen M. Pathophysiology of the migraine aura. The spreading depression theory. Brain 117 (1994) 199-210
67. Leão A.A.P. Further observations on the spreading depression of activity in the cerebral cortex. J. Neurophysiol. 10 (1944) 409-414
68. Leão A.A.P. Spreading depression of activity in the cerebral cortex. J. Neurophysiol. 7 (1944) 359-390
69. Lipton R.B., Stewart W.F., Diamond S., Diamond M.L., and Reed M. Prevalence and burden of migraine in the United States: Data from the American Migraine Study II. Headache 41 (2001) 646-657
70. Ludvigsson P., Hesdorffer D., Olafsson E., Kjartansson O., and Hauser W.A. Migraine with aura is a risk factor for unprovoked seizures in children. Ann. Neurol. 59 (2006) 210-213
71. Marconi R., De Fusco M., Aridon P., Plewnia K., Rossi M., Carapelli S., Ballabio A., Morgante L., Musolino R., Epifanio A., Micieli G., De Michele G., and Casari G. Familial hemiplegic migraine type 2 is linked to 0.9Mb region on chromosome 1q23. Ann. Neurol. 53 (2003) 376-381
72. Marti S., Baloh R.W., Jen J.C., Straumann D., and Jung H.H. Progressive cerebellar ataxia with variable episodic symptoms-Phenotypic diversity of R1668W CACNA1A mutation. Eur. Neurol. 60 (2008) 16-20
73. Matharu M.S., and Goadsby P.J. Post-traumatic chronic paroxysmal hemicrania (CPH) with aura. Neurology 56 (2001) 273-275
74. McGrail K.M., Phillips J.M., and Sweadner K.J. Immunofluorescent localization of three Na,K-ATPase isozymes in the rat central nervous system: Both neurons and glia can express more than one Na,K-ATPase. J. Neurosci. 11 (1991) 381-391
75. Meisler M.H., and Kearney J.A. Sodium channel mutations in epilepsy and other neurological disorders. J. Clin. Invest. 115 (2005) 2010-2017
76. Melliti K., Grabner M., and Seabrook G.R. The familial hemiplegic migraine mutation R192Q reduces G-protein-mediated inhibition of P/Q-type (Ca(V)2.1) calcium channels expressed in human embryonic kidney cells. J. Physiol. 546 (2003) 337-347
77. Menken M., Munsat T.L., and Toole J.F. The global burden of disease study-Implications for neurology. Arch. Neurol. 57 (2000) 418-420
78. Moseley A.E., Lieske S.P., Wetzel R.K., James P.F., He S., Shelly D.A., Paul R.J., Boivin G.P., Witte D.P., Ramirez J.M., Sweadner K.J., and Lingrel J.B. The Na,K-ATPase alpha 2 isoform is expressed in neurons, and its absence disrupts neuronal activity in newborn mice. J. Biol. Chem. 278 (2003) 5317-5324
79. Mulder E.J., Van Baal C., Gaist D., Kallela M., Kaprio J., Svensson D.A., Nyholt D.R., Martin N.G., MacGregor A.J., Cherkas L.F., Boomsma D.I., and Palotie A. Genetic and environmental influences on migraine: A twin study across six countries. Twin Res. 6 (2003) 422-431
80. 2+ channel gating: Evidence for beta-subunit isoform-specific effects. J. Biol. Chem. 279 (2004) 51844-51850
81. Nyholt D.R., Gillespie N.G., Heath A.C., Merikangas K.R., Duffy D.L., and Martin N.G. Latent class and genetic analysis does not support migraine with aura and migraine without aura as separate entities. Genet. Epidemiol. 26 (2004) 231-244
82. Ogiwara I., Miyamoto H., Morita N., Atapour N., Mazaki E., Inoue I., Takeuchi T., Itohara S., Yanagawa Y., Obata K., Furuichi T., Hensch T.K., and Yamakawa K. Na(v)1.1 localizes to axons of parvalbumin-positive inhibitory interneurons: A circuit basis for epileptic seizures in mice carrying an Scn1a gene mutation. J. Neurosci. 27 (2007) 5903-5914
83. Ohmori I., Ouchida M., Ohtsuka Y., Oka E., and Shimizu K. Significant correlation of the SCN1A mutations and severe myoclonic epilepsy in infancy. Biochem. Biophys. Res. Commun. 295 (2002) 17-23
84. 2+ channel gene CACNL1A4. Cell 87 (1996) 543-552
85. Peres M.F.P., Siow H.C., and Rozen T.D. Hemicrania continua with aura. Cephalalgia 22 (2002) 246-248
86. Piedras-Rentería E.S., Barrett C.F., Cao Y.Q., and Tsien R.W. Voltage-gated calcium channels, calcium signaling, and channelopathies. In: Krebs J., and Michalek M. (Eds). Calcium: A Matter of Life or Death (2007), Elsevier, New York 127-166
87. Piper R.D., Lambert G.A., and Duckworth J.W. Cortical blood flow changes during spreading depression in cats. Am. J. Physiol. 261 (1991) H96-H102
88. Radat F., and Swendsen J. Psychiatric comorbidity in migraine: A review. Cephalalgia 25 (2005) 165-178
89. Riant F., De Fusco M., Aridon P., Ducros A., Ploton C., Marchelli F., Maciazek J., Bousser M.G., Casari G., and Tournier-Lasserve E. ATP1A2 mutations in 11 families with familial hemiplegic migraine. Hum. Mutat. 26 (2005) 281
90. Rothstein J.D., Dykes-Hoberg M., Pardo C.A., Bristol L.A., Jin L., Kuncl R.W., Kanai Y., Hediger M.A., Wang Y., Schielke J.P., and Welty D.F. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 16 (1996) 675-686
91. Russell M.B., and Olesen J. Increased familial risk and evidence of genetic factor in migraine. Br. Med. J. 311 (1995) 541-544
92. Russell M.B., and Olesen J. A nosographic analysis of the migraine aura in a general population. Brain 119 (1996) 355-361
93. Russell M.B., Ulrich V., Gervil M., and Olesen J. Migraine without aura and migraine with aura are distinct disorders. A population-based twin survey. Headache 42 (2002) 332-336
94. Scher A.I., Stewart W.F., and Lipton R.B. Migraine and headache: A meta-analytic approach. In: Crombie I.K. (Ed). Epidemiology of Pain (1999), IASP Press, Seattle, WA 159-170
95. Segall L., Scanzano R., Kaunisto M.A., Wessman M., Palotie A., Gargus J.J., and Blostein R. Kinetic alterations due to a missense mutation in the Na,K-ATPase alpha2 subunit cause familial hemiplegic migraine type 2. J. Biol. Chem. 279 (2004) 43692-43696
96. Segall L., Mezzetti A., Scanzano R., Gargus J.J., Purisima E., and Blostein R. Alterations in the alpha2 isoform of Na,K-ATPase associated with familial hemiplegic migraine type 2. Proc. Natl Acad. Sci. USA 102 (2005) 11106-11111
97. Silberstein S.D., Niknam R., Rozen T.D., and Young W.B. Cluster headache with aura. Neurology 54 (2000) 219-221
98. Silberstein S.D., Lipton R.B., and Goadsby P.J. Headache in Clinical Practice (2002), Martin Dunitz, London
99. Somjen G.G. Mechanisms of spreading depression and hypoxic spreading depression-like depolarization. Physiol. Rev. 81 (2001) 1065-1096
100. Spacey S.D., Hildebrand M.E., Materek L.A., Bird T.D., and Snutch T.P. Functional implications of a novel EA2 mutation in the P/Q-type calcium channel. Ann. Neurol. 56 (2004) 213-220
101. +-ATPase mutation causes familial hemiplegic migraine type 2 with cerebellar signs. Neurogenetics 5 (2004) 177-185
102. Stam A.H., van den Maagdenberg A.M., Haan J., Terwindt G.M., and Ferrari M.D. Genetics of migraine: An update with special attention to genetic comorbidity. Curr. Opin. Neurol. 21 (2008) 288-293
103. Stewart W.F., Staffa J., Lipton R.B., and Ottman R. Familial risk of migraine: A population-based study. Ann. Neurol. 41 (1997) 166-172
104. Stewart W.F., Ricci J.A., Chee E., Morganstein D., and Lipton R. Lost productive time and cost due to common pain conditions in the US workforce. JAMA 290 (2003) 2443-2454
105. Stewart W.F., Bigal M.E., Kolodner K., Dowson A., Liberman J.N., and Lipton R.B. Familial risk of migraine: Variation by proband age at onset and headache severity. Neurology 66 (2006) 344-348
106. Svensson D.A., Larsson B., Waldenlind E., and Pedersen N.L. Shared rearing environment in migraine: Results from twins reared apart and twins reared together. Headache 43 (2003) 235-244
107. Swoboda K.J., Kanavakis E., Xaidara A., Johnson J.E., Leppert M.F., Schlesinger-Massart M.B., Ptacek L.J., Silver K., and Youroukos S. Alternating hemiplegia of childhood or familial hemiplegic migraine? A novel ATP1A2 mutation. Ann. Neurol. 55 (2004) 884-887
108. Terwindt G.M., Ophoff R.A., Haan J., Vergouwe M.N., van Eijk R., Frants R.R., and Ferrari M.D. Variable clinical expression of mutations in the P/Q-type calcium channel gene in familial hemiplegic migraine. Neurology 50 (1998) 1105-1110
109. Terwindt G., Kors E., Haan J., Vermeulen F., Van den Maagdenberg A., Frants R., and Ferrari M. Mutation analysis of the CACNA1A calcium channel subunit gene in 27 patients with sporadic hemiplegic migraine. Arch. Neurol. 59 (2002) 1016-1018
110. Thomsen L.L., Ostergaard E., Olesen J., and Russell M.B. Evidence for a separate type of migraine with aura: Sporadic hemiplegic migraine. Neurology 60 (2003) 595-601
111. Thomsen L.L., Ostergaard E., Romer S.F., Andersen I., Eriksen M.K., Olesen J., and Russell M.B. Sporadic hemiplegic migraine is an aetiologically heterogeneous disorder. Cephalalgia 23 (2003) 921-928
112. Todt U., Dichgans M., Jurkat-Rott K., Heinze A., Zifarelli G., Koenderink J.B., Goebel I., Zumbroich V., Stiller A., Ramirez A., Friedrich T., Gobel H., and Kubisch C. Rare missense variants in ATP1A2 in families with clustering of common forms of migraine. Hum. Mutat. 26 (2005) 315-321
113. V 2.1 current density in neurons. Proc. Natl Acad. Sci. USA 99 (2002) 13284-13289
114. Tottene A., Pivotto F., Fellin T., Cesetti T., van den Maagdenberg A.M., and Pietrobon D. Specific kinetic alterations of human CaV2.1 calcium channels produced by mutation S218L causing familial hemiplegic migraine and delayed cerebral edema and coma after minor head trauma. J. Biol. Chem. 280 (2005) 17678-17686
115. Ulrich V., Gervil M., Kyvik K.O., Olesen J., and Russell M.B. Evidence of a genetic factor in migraine with aura: A population based Danish twin study. Ann. Neurol. 45 (1999) 242-246
116. van den Maagdenberg A.M.J.M., Pietrobon D., Pizzorusso T., Kaja S., Broos L.A.M., Cesetti T., van de Ven R.C.G., Tottene A., van der Kaa J., Plomp J.J., Frants R.R., and Ferrari M.D. A Cacna1a knock-in migraine mouse model with increased susceptibility to cortical spreading depression. Neuron 41 (2004) 701-710
117. van den Maagdenberg A.M., Haan J., Terwindt G.M., and Ferrari M.D. Migraine: Gene mutations and functional consequences. Curr. Opin. Neurol. 20 (2007) 299-305
118. +-ATPase pump gene ATP1A2 associated with familial hemiplegic migraine and benign familial infantile convulsions. Ann. Neurol. 54 (2003) 360-366
119. Vanmolkot K.R., Kors E.E., Turk U., Turkdogan D., Keyser A., Broos L.A., Kia S.K., van den Heuvel J.J., Black D.F., Haan J., Frants R.R., Barone V., Ferrari M.D., Casari G., Koenderink J.B., and van den Maagdenberg A.M. Two de novo mutations in the Na,K-ATPase gene ATP1A2 associated with pure familial hemiplegic migraine. Eur. J. Hum. Genet. 14 (2006) 555-560
120. Vanmolkot K.R., Babini E., de Vries B., Stam A.H., Freilinger T., Terwindt G.M., Norris L., Haan J., Frants R.R., Ramadan N.M., Ferrari M.D., Pusch M., van den Maagdenberg A.M., and Dichgans M. The novel p.L1649Q mutation in the SCN1A epilepsy gene is associated with familial hemiplegic migraine: Genetic and functional studies. Mutation in brief #957. Online. Hum. Mutat. 28 (2007) 522
121. Wakamori M., Yamazaki K., Matsunodaira H., Teramoto T., Tanaka I., Niidome T., Sawada K., Nishizawa Y., Sekiguchi N., Mori E., Mori Y., and Imoto K. Single tottering mutations responsible for the neuropathic phenotype of the P-Type calcium channel. J. Biol. Chem. 273 (1998) 34857-34867
122. Wan J., Khanna R., Sandusky M., Papazian D.M., Jen J.C., and Baloh R.W. CACNA1A mutations causing episodic and progressive ataxia alter channel trafficking and kinetics. Neurology 64 (2005) 2090-2097
123. 2+ channel Cav2.1 missense mutations associated with episodic ataxia type 2 and progressive ataxia. J. Biol. Chem. 277 (2002) 6960-6966
124. Woods R.P., Iacoboni M., and Mazziotta J.C. Bilateral spreading cerebral hypoperfusion during spontaneous migraine headache. N. Engl. J. Med. 331 (1994) 1689-1692
125. Yu F.H., and Catterall W.A. Overview of the voltage-gated sodium channel family. Genome Biol. 4 (2003) 207
126. Yu F.H., Mantegazza M., Westenbroek R.E., Robbins C.A., Kalume F., Burton K.A., Spain W.J., McKnight G.S., Scheuer T., and Catterall W.A. Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy. Nat. Neurosci. 9 (2006) 1142-1149
127. Yue Q., Jen J.C., Nelson S.F., and Baloh R.W. Progressive ataxia due to a missense mutation in a calcium-channel gene. Am. J. Hum. Genet. 61 (1997) 1078-1087
128. Zhuchenko O., Bailey J., Donnen P., Ashizawa T., Stockton D.W., Amos C., Dobyns W.B., Subramony S.H., Zoghbi H.Y., and Lee C.C. Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the α1A-voltage-dependent calcium channel. Nat. Genet. 15 (1997) 62-69
129. Ziegler D.K., Hur Y.M., Bouchard Jr. T.J., Hassanein R.S., and Barter R. Migraine in twins raised together and apart. Headache 38 (1998) 417-422